title: Primary squamous cell carcinoma of the prostate.
abstract: BACKGROUND
  Primary squamous cell carcinoma (SCC) is an uncommon tumor of the prostate gland. A 65-year old man complained of obstructive symptoms.
  
  
  RESULTS
  Transrectal palpation and diagnostic imaging indicated an ordinary adenocarcinoma, although serum prostate-specific antigen (PSA) was normal. Biopsy specimens revealed SCC with the serum SCC antigen elevated. The patient was treated with pelvic irradiation and systemic administration of cis-platinum and peplomycin, which resulted in shrinkage of the cancer.
  
  
  CONCLUSIONS
  No evidence of recurrence has been seen for 18 months.
authors.affiliation: Department of Urology, Hamanomachi Hospital, Fukuoka, Japan. MHD00035@nifty.ne.jp
authors.forename: E
authors.initials: E
authors.lastname: Okada
authors.forename: H
authors.initials: H
authors.lastname: Kamizaki
mesh_terms: D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D017663:Peplomycin / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed
chemical_list: D000903:Antibiotics, Antineoplastic; D011838:Radiation-Sensitizing Agents; D017663:Peplomycin; D002945:Cisplatin